Angiogenesis in pituitary adenomas

Microscopy Research and Technique

Volumn 60, Issue 2, 2003, Pages 236-243

  Yamada, Shozo ^a   Takada, Kouji ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Microvessel density; Pituitary adenoma; Pituitary gland; Vascular endothelial growth factor

Indexed keywords

BLOOD VESSELS; CELL CULTURE; ENDOTHELIAL CELLS; FIBROBLASTS; MICROCIRCULATION; PATHOLOGY;

ANGIOGENESIS; BASIC FIBROBLAST GROWTH FACTOR; IMMUNOHISTOCHEMICAL MARKERS; INVASIVENESS; MICROVESSEL DENSITY; PITUITARY ADENOMA; PITUITARY GLAND; TUMOR GROWTH; TUMOR METASTASIS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

TUMORS;

BASIC FIBROBLAST GROWTH FACTOR; KI 67 ANTIGEN; VASCULOTROPIN;

ADENOHYPOPHYSIS; ANGIOGENESIS; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METASTASIS; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

EID: 0037301964     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10262     Document Type: Review

References (82)

1. Baird A, Mormede P, Ying SY, Wehrenberg WB, Ueno N, Ling N, Guillemin R. 1985. A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. Proc Natl Acad Sci USA 82:5545-5549.
2. Banerjee SK, Sarker DK, Weston AP, De A, Campbell DR. 1997. Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Cartinogenesis 18:1155-1161.
3. Banerjee SK, Zoubine MN, Tran T, Weston AP, Campbell DR. 2000. Overexpression of vascular endothelial growth factor 164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 16:253-260.
4. Bikfalvi A, Klein S, Pintucci G, Quarto N, Mignatti P, Rifkin DB. 1995. Differential modulation of cell phenotype by different molecular weight forms of basis fibroblast growth factor: possible intra-cellular signaling by the high molecular weight forms. J Cell Biol 129:233-243.
5. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. 1997. Biological roles of fibroblast growth factor-2. Endocr Rev 18:26-45.
6. Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, Nichols PW. 1995. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87:603-1612.
7. Bonneville JF, Cattin F, Corczyca W, Hardy J. 1993. Pituitary microadenomas: early enhancement with dynamic CT-implications of arterial blood supply and potential importance. Radiology 187:857-861.
8. Brem SS, Gullino PM, Medina D. 1978. Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 41:239-244.
9. Colao A, DiSarno A, Marzullo P, DiSomma C, Cerbone G, Faggiano A, Merola B, Lombardi G. 2000. New medical approaches in pituitary adenomas. Horm Res 53(Suppl 3):76-87.
10. Cordon CC, Vlodavski I, Haimovitz FA, Hicklin D, Fuks Z. 1990. Expression of basic fibroblast growth factor in human normal tissues. Lab Invest 63:832-840.
11. Danesi R, Agen C, Benelli U, Paolo AD, Nardini D, Bocci G, Bosolo F, Campagni A, Tacca MD. 1997. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS201-995). Clin Cancer Res 3:265-272.
12. Delgrange E, Trouillas J, Maiter D, Donckier J, Turnaire J. 1997. Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82:2102-2107.
13. Elias KA, Weiner RI. 1987. Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fisher 344 rats. Endocrinology 120:617-621.
14. Erroi A, Bassetti M, Spada A, Giannattasio G. 1986. Microvasculature of human micro- and macroprolactinomas. Neuroendocrinology 43:159-165.
15. Ezzat S, Smith HS, Ramyar L, Asa SL. 1995. Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J Clin Endocrinol Metab 80:878-884.
16. Fan L, Iseki S. 1998. Immunohistochemical localization of vascular endothelial growth factor in the endocrine glands of the rat. Arch Histol Cytol 61:17-28.
17. Farnoud MR, Kujas M, Derome P, Racadot J, Peillon F, Li JY. 1994. Interactions between normal and tumoral tissue at the boundary of human anterior pituitary adenomas. Virchows Arch 424:75-82.
18. Ferrara NK, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
19. Ferrara N, Leung DW, Cachianes G, Winer J, Henzel WJ. 1991. Purification and cloning of vascular endothelial growth factor secreted by folliculo-stellate cells. Methods Enzymol 198:391-405.
20. Folkman J. 1990. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6.
21. Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267:10931-10934.
22. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31.
23. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavski I. 1988. A heparin-binding angiogenesis protein-basic fibroblast growth factor is stored within basement membrane. Am J Pathol 130:393-400.
24. Fukumara D, Xavier R, Sugiura T, Chen Y, Park E, Lu N, Selig M, Nielsen G, Taksir T, Jain RJ, Seed B. 1998. Tumor induction of VEGF promoter activity in stromal cells. Cell 94:715-725.
25. Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P. 1995. Predictive and prognosis markers in a series of patients with head and neck squamous-cell invasive carcinoma treated with concurrent chemoradiation therapy. Clin Can Res 1:1375-1383.
26. Gloddek J, Pagotto U, Pereda MP, Arzt E, Stalla GK, Renner U. 1999. Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. J Endocrinol 160:483-490.
27. Gorczyca W, Hardy J. 1987. Arterial supply of the human anterior pituitary gland. Neurosurgery 20:369-378.
28. Gorczyca W, Hardy J. 1988. Microadenomas of the human pituitary and their vascularization. Neurosurgery 22:1-6.
29. Gospodarowicz D, Abraham JA, Schilling J. 1989. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86:7311-7315.
30. Heaney A, Horwitz GA, Wang Z, Singson R, Melmed S. 1999. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nature Med 5:1317-1321.
31. Hirano A, Tomiyasu U, Zimmerman HM. 1972. The fine structure of blood vessels in chromophobe adenoma. Acta Neuropathol 22:200-207.
32. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL. 1992. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120-1124.
33. Iuchi T, Saeki N, Osato K, Yamaura A. 2000. Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas. Acta Neurochir 142:1345-1351.
34. Jabbour HN, Boddy SC, Lincoln GA. 1997. Pattern and localization of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: expression is independent of hypothalamic control. Mol Cell Endocrinol 134:91-100.
35. Jain RK. 2001. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nature Med 7:987-989.
36. Jensen HM, Chen I, DeVault MR, Lewis AE. 1982. Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer. Science 218:293-295.
37. Jin L, Chandler WF, Lloyd RV. 1994. Localization of basic fibroblast growth factor (bFGF) protein and mRNA in human pituitaries; regulation of bFGF mRNA by gonadotropin-releasing hormone. Endocr Pathol 5:27-34.
38. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. 1995. Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphological study. Endocr Pathol 6:115-124.
39. Kerbel RS. 2000. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21:505-515.
40. Knighton DR, Figel VD. 1991. Regulation of cutaneous wound healing by growth factors and microenvironment. Invest Radiol 26:604-611.
41. Kovacs K, Horvath E. 1972. Vascular alterations in adenomas of human pituitary glands. Angiologica 10:299-309.
42. Lebovic DI, Mueller MD, Taylor RN. 1999. Vascular endothelial growth factor in reproductive biology. Curr Opin Obstet Gynecol 11:255-260.
43. Li Y, Koga M, Kasayama S, Matsumoto K, Arita N, Hayakawa T, Sato B. 1992. Identification and characterization of high molecular weigh forms of basic fibroblast growth factor in human pituitary adenomas. J Clin Endocrinol Metab 75:1436-1441.
44. Liotta LA, Steeg PS, Stetler-Stevenson WG. 1991. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336.
45. List CF, Williams JR, Balyeat GW. 1952. Vascular lesions in pituitary adenomas. J Neurosurg 9:177-187.
46. Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L. 1999. Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol 10:229-235.
47. Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, Stalla GK, Renner U. 2001. Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 74:95-105.
48. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. 1992. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 340:145-146.
49. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico G. 1991. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271.
50. Marin F, Kovacs K, Stefaneanu L, Horvath E, Cheng Z. 1992. S-100 protein immunopositivity in human nontumorous hypophyses and pituitary adenomas. Endocr Pathol 3:28-38.
51. Nomura M, Yamagishi S, Harada S, Yamashita T, Yamashita J, Yamamoto H. 1998. Placenta growth factor (PIGF) mRNA expression in brain tumors. J. Neurooncol 40:123-130.
52. Pawlikowski M, Pisaret H, Jaranowska M. 1997. Immunocytochemical investigations on the vascularization of pituitary adenomas. Endocr Pathol 8:189-193.
53. Pepper MS, Ferrara N, Orci L, Montesano R. 1992. Potent synergism between vascular endothelial growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824-831.
54. Pernicone PJ, Scheithauer BW. 1993. Invasive pituitary adenomas and pituitary carcinomas. In: Lloyd RV, editor. Surgical pathology of the pituitary gland. Philadephia: W.B. Saunders p 121-136.
55. Renner U, Pagotto U, Arzt E, Stalla GK. 1996. Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review. Eur J Endocrinol 135:515-532.
56. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
57. Rivad A, Fabre J, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM. 1999. Age-dependent impairment of angiogenesis. Circulation 99:111-120.
58. Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohono K, Kuwano M. 1996. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271:28220-28228.
59. Schechter J. 1972. Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 67:109-120.
60. Schechter J, Weiner R. 1991. Changes in basic fibroblast growth factor coincident with estradiol-induced hyperplasia of the anterior pituitaries of Fischer 344 and Sprague-Dawley rats. Endocrinology 129:2400-2408.
61. Schechter J, Goldsmith P, Wilson C, Weiner R. 1988. Morphological evidence for the presence of arteries in human prolactinomas. J Clin Endocrinol Metab 67:713-719.
62. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P. 1998. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659-1673.
63. Semenza GL. 1996. Transcriptional regulation by hypoxia-inducible factor 1-molecular mechanisms of oxygen homeostasis. Trends Cardiovasc Med 6:151-157.
64. Shweiki D, Itin A, Soffer D, Keshet E. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
65. Siitonen SM, Haapasalo HK, Rantala IS, Helin HJ, Isola JJ. 1995. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol 8:745-752.
66. Smals AEM, Pieters GFFM, Smals AGH, Kloppenborg PWC. 1988. Sex difference in the relation between sellar volume and basal and GH-releasing hormone stimulated GH in acromegaly. Acta Endocrinol 117:387-391.
67. Stepien H, Grochal M, Zielinski KW, Mucha S, Kunert-Radek J, Kulig A, Pisarek H. 1996. Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats. J Endocrinol 150:99-106.
68. Suzuki H, Takahashi JA, Fukumoto M, Hashimoto N, Itoh N, Hatanaka M, Kikuchi H. 1994. Immunohistochemical study for basic fibroblast growth factor and fibroblast growth factor receptor 1 in pituitary adenomas. Neurosci Lett 171:192-196.
69. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER. 1996. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99-107.
70. Turner HE, Wass JAH. 1999 Are markers of proliferation valuable in the histological assessment of pituitary tumours? Pituitary 1:147-151.
71. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JAH. 2000a. Angiogenesis in pituitary adenomas-relationship to endocrine function, treatment and outcome. Clin Endocrino 165:475-481.
72. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JAH. 2000b. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 85:1159-1162.
73. Turner HE, Nagy Zs, Gatter KC, Esiri MM, Wass JAH, Harris AL. 2000c. Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behavior. Br J Cancer 82:1441-1445.
74. Vermeulen PB, Dirix LY, Libura J, Vanhoolst IF, Van Marck E, Oosterom AT. 1997. Correlation of the fractions of proliferating tumor and endothelial cells in breast and colorectal adenocarcinoma is independent of tumor histiotype and microvessel density. Microvasc Res 54:88-92.
75. Vidal SV, Kovacs K, Cohen SM, Stefaneanu L, Lloid RV, Scheithauer BW. 1999a. Localization of vascular endothelial growth factor in nontumorous human pituitaries. Endocr Pathol 10:109-122.
76. Vidal S, Stefaneanu L, Kovacs K, Scheithauer BW. 1999b. Expression of von Hippel-Lindau protein (VHL-P) in nontumorous and adenomatous human pituitaries. Pituitary 1:227-232.
77. Vidal S, Oliveira MC, Kovacs K, Scheithauer BW, Lloyd R. 2000. Immunolocalization of vascular endothelial growth factor in the GH3 cell line. Cell Tissue Res 300:83-88.
78. Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloid RV. 2001. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438:595-602.
79. Vogel AW. 1965. Intratumoral vascular changes with increased size of a mammary adenocarcinoma: new methods and results. J Nat Cancer Inst 34:571-578.
80. Weidner N, Semple JP, Welch WR, Folkman J. 1991. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324:1-8.
81. Weidner N, Carrol PR, Flax J, Blumenfeld W, Folkman J. 1993. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409.
82. Yun WTC, Fisher DJ, Nguyen HD, Tali ET, Gao F, Simonson TM, Schlechte JA. 1994. Sequential MR enhancement pattern in normal pituitary gland and in pituitary adenoma. Am J Neuroradiol 15:101-108.